US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Cronus Pharma LLC
Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs
October 01, 2026
From
Cronus Pharma LLC
Via
Business Wire
Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use
August 26, 2026
From
Cronus Pharma LLC
Via
Business Wire
Cronus Pharma Introduces Pimobendan Chewable Tablets (First FDA-Approved Generic) for Veterinary Use
June 09, 2026
From
Cronus Pharma LLC
Via
Business Wire
Cronus Pharma Launches Butorphic® (Butorphanol Tartrate) Sterile Injectable Solution
July 21, 2025
From
Cronus Pharma LLC
Via
Business Wire
Cronus Pharma Hires Todd Brodersen as Senior Director of Sales & Marketing
December 22, 2021
From
Cronus Pharma LLC
Via
Business Wire